Duality Biotherapeutics, Inc. (HKG:9606)

Duality Biotherapeutics Statistics

Total Valuation

HKG:9606 has a market cap or net worth of HKD 28.84 billion. The enterprise value is 25.26 billion.

Market Cap	28.84B
Enterprise Value	25.26B

Important Dates

The last earnings date was Monday, March 23, 2026.

Earnings Date	Mar 23, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:9606 has 90.14 million shares outstanding. The number of shares has increased by 714.45% in one year.

Current Share Class	90.14M
Shares Outstanding	90.14M
Shares Change (YoY)	+714.45%
Shares Change (QoQ)	+112.47%
Owned by Insiders (%)	12.76%
Owned by Institutions (%)	34.96%
Float	50.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.00
PB Ratio	10.68
P/TBV Ratio	10.70
P/FCF Ratio	n/a
P/OCF Ratio	133.21
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.75
EV / Sales	12.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.06.

Current Ratio	3.65
Quick Ratio	3.51
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-380.27

Financial Efficiency

Return on equity (ROE) is -1,282.14% and return on invested capital (ROIC) is -102.74%.

Return on Equity (ROE)	-1,282.14%
Return on Assets (ROA)	-9.61%
Return on Invested Capital (ROIC)	-102.74%
Return on Capital Employed (ROCE)	-16.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	8.92M
Profits Per Employee	-12.50M
Employee Count	231
Asset Turnover	0.62
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+56.10%
50-Day Moving Average	307.85
200-Day Moving Average	327.08
Relative Strength Index (RSI)	56.91
Average Volume (20 Days)	1,072,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9606 had revenue of HKD 2.06 billion and -2.89 billion in losses. Loss per share was -44.32.

Revenue	2.06B
Gross Profit	655.55M
Operating Income	-512.03M
Pretax Income	-2.89B
Net Income	-2.89B
EBITDA	-498.32M
EBIT	-512.03M
Loss Per Share	-44.32

Balance Sheet

The company has 3.75 billion in cash and 166.67 million in debt, with a net cash position of 3.59 billion or 39.80 per share.

Cash & Cash Equivalents	3.75B
Total Debt	166.67M
Net Cash	3.59B
Net Cash Per Share	39.80
Equity (Book Value)	2.70B
Book Value Per Share	30.48
Working Capital	3.10B

Cash Flow

Operating Cash Flow	216.53M
Capital Expenditures	n/a
Depreciation & Amortization	14.13M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 31.81%, with operating and profit margins of -24.85% and -140.13%.

Gross Margin	31.81%
Operating Margin	-24.85%
Pretax Margin	-140.13%
Profit Margin	-140.13%
EBITDA Margin	-24.18%
EBIT Margin	-24.85%
FCF Margin	n/a

Dividends & Yields

HKG:9606 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-714.45%
Shareholder Yield	-714.45%
Earnings Yield	-10.01%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9606 has an Altman Z-Score of 9.16 and a Piotroski F-Score of 2.

Altman Z-Score	9.16
Piotroski F-Score	2